Skip to content
ClinCalc Pro
Menu
Corticosteroid (Oral)

Prednisolone 1mg/kg/day (max 60–80mg)

Brand names: Deltacortril, Predsol

Prednisolone is an oral glucocorticoid; in nephrology, weight-based regimens are used as immunosuppression for glomerular diseases such as minimal change disease and other immune-mediated nephropathies. This entry covers that high-dose induction context.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It binds intracellular glucocorticoid receptors to modulate transcription of inflammatory and immune genes, suppressing cytokine production, leucocyte activity and the immune injury underlying many glomerular diseases.

Prescribing in practice

  • Do not stop prolonged or high-dose corticosteroid therapy abruptly because of the risk of adrenal crisis; the dose must be tapered and a steroid emergency card issued.
  • Prolonged use causes hyperglycaemia, hypertension, osteoporosis, weight gain and increased infection risk, so gastroprotection, bone protection and infection vigilance should be considered.
  • Live vaccines are generally contraindicated during significant immunosuppression, and chickenpox or measles exposure in a non-immune patient needs urgent attention.

Monitoring

Monitor blood pressure, blood glucose, weight, bone health and signs of infection, alongside the renal parameters guiding treatment response.

Counselling the patient

  • Never stop the steroid suddenly and carry your steroid emergency card.
  • Take it in the morning with food and report signs of infection.
  • Tell any clinician you are taking steroids, especially if you become unwell.

Evidence & guidelines

Corticosteroids are a long-established mainstay of immune-mediated glomerular disease, with current prescribing references and the SPC underpinning their use and withdrawal rules.

Reference: ISKDC Protocol; KDIGO Nephrotic Syndrome Guidelines 2021; NICE Osteoporosis in corticosteroid users guidance; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.